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ABSTRACT
Background: Autism spectrum disorder (ASD) is a
developmental disorder of the central nervous system of
largely unknown aetiology. The prevalence of the
syndrome underscores the need for biological markers
and a clearer understanding of pathogenesis. For these
reasons, a genetic study of idiopathic ASD was under-
taken.
Methods and results: Array based comparative
genomic hybridisation identified a paternally inherited
chromosome 3 copy number variation (CNV) in three
subjects: a deletion in two siblings and a duplication in a
third, unrelated individual. These variations were fluores-
cence in situ hybridisation (FISH) validated and the end
points further delineated using a custom fine tiling
oligonucleotide array. Polymerase chain reaction (PCR)
products unique to the rearrangements were amplified
and sequence analysis revealed the variations to have
resulted from Alu Y mediated unequal recombinations
interrupting contactin 4 (CNTN4).
Conclusion: CNTN4 plays an essential role in the
formation, maintenance, and plasticity of neuronal net-
works. Disruption of this gene is known to cause
developmental delay and mental retardation. This report
suggests that mutations affecting CNTN4 function may be
relevant to ASD pathogenesis.
Autism spectrum disorder (ASD) (Online
Mendelian Inheritance in Man (OMIM) 209850)
is a severe developmental disorder of the central
nervous system characterised by impairments in
three behavioural areas: (1) social interaction; (2)
verbal and non-verbal communication; and (3)
range of interests, activities and patterns of
behaviour.
1 The disorder is divided into five
DSM-IV (Diagnostic and statistical manual of mental
disorders, 4th ed) subtypes: autistic disorder,
Asperger disorder, disintegrative disorder, pervasive
developmental disorder not otherwise specified
(PDD-NOS), and Rett disorder.
1 With the excep-
tion of Rett disorder, reliable biological markers do
not exist for diagnosis or classification.
2 Given the
prevalence of ASD (as high as 1 in 150 American
children), a clearer understanding of aetiology is
necessary both for diagnostic and therapeutic
purposes.
3
Pathogenesis of ASD has been argued to be both
environmental and biological.
4 Of the different
biological causes associated with the disorder,
genetic factors are the most important. Family
studies demonstrate that the recurrence risk for an
affected proband’s sibling is between 2–10%.
5 This
is 3–15 times the population risk for ASD.
3 Same
sex twin studies report an average concordance
rate of 60–90% between monozygotic twins,
compared with 0–10% in dizygotic twins.
6 These
twin findings support genetic inheritance as a
major causative agent in ASD, but also suggest
that epigenetic factors and exposure to environ-
mental agents may contribute to the variable
expression of autism traits, acting as modifiers in
genetically susceptible individuals. The prevalence
of communication disorders, social phobias and
obsessive–compulsive disorder in non-autistic
family members of autistic patients also implies
that the expression of autism related traits is
variable.
7
This report describes copy number variations
(CNVs) disrupting the same gene, contactin 4
(CNTN4), in three individuals with ASD. In each
instance, the mutation resulted from an Alu Y
mediated unequal recombination event. Alu ele-
ments have inserted into about one million sites of
the human genome, accounting for about 10% of
total genomic DNA.
8 They are hotspots for
recombination with Alu mediated rearrangement,
resulting in approximately 0.3% of all genetic
disease.
9 The youngest subfamilies, including Y,
Yc1, Yc2, Ya5, Ya5a2, Ya8, Yb8 and Yb9, have the
greatest homology, and therefore are most likely to
recombine.
9
METHODS
Participants
Participants were recruited from the Cody Center
for Autism and Developmental Disabilities clinic
for an institutional review board approved genetics
study. Initial evaluations for ASD had been
performed by a multidisciplinary diagnostic team,
supervised by an experienced developmental dis-
abilities specialist (JCP). Evaluations included
review of extensive behavioural, developmental
and demographic information completed by care-
givers and teachers, and a semi-structured parent
interview. If, on further review for entry to this
study, information regarding diagnosis was felt to
be equivocal or incomplete, the Autism Diagnostic
Observation Schedule (ADOS) and/or the Autism
Diagnostic Interview-Revised were administered. A
total of 92 subjects with ASD as well as both of
their biological parents were enrolled and com-
pleted the study. Participants in the study came
from 81 different families.
Individuals fulfilling the criteria for ASD under-
went a physical examination at the General
Clinical Research Center (Stony Brook University
Medical Center (SBUMC)) conducted by a medical
geneticist (DHT) and a blood sample was obtained
from each subject for DNA isolation, conventional
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testing, and, if indicated, Rett MECP2 testing. A blood sample
was also obtained from the subject’s parents for DNA isolation.
DNA isolation, peripheral blood karyotyping, and fragile X
testing were performed by the Cytogenetics and Molecular
Genetics Laboratories of the SBUMC using standard methods.
Participants were excluded from the study if a Rett MECP2 or a
fragile X mutation was discovered. DNA and medical records
were coded to ensure confidentiality.
Whole genome array comparative genomic hybridisation and
fluorescent in situ hybridisation
Genomic DNA from all subjects (and parents, in select cases)
was hybridised onto tiling path bacterial artificial chromosome
(BAC) arrays for copy number analysis as previously described.
10
Image analysis was performed using the BlueFuse package
(BlueGnome, Cambridge, UK). A subgrid loss corrected log2
ratio of the background subtracted test/control was calculated
for each clone. Fluorescence in situ hybridisation (FISH)
validation of genomic DNA CNVs was performed with Phi29
DNA polymerase amplified BAC clones as previously
described.
11 Three BAC clones were selected for each FISH
experiment: (1) a left clone flanking the CNV (proximal to the
centromere) was labelled with Biotin (Roche, Nutley, New
Jersey, USA) detected with Streptavidin Cy5 (Jackson
Immunoresearch Laboratories, West Grove, Pennsylvania,
USA) and pseudocoloured in yellow; (2) a right clone flanking
the CNV (distal to the centromere) was labelled with Spectrum
Green dNTP (1.6 nmole, Vysis, Abbott Molecular Inc, Des
Plaines, Illinois, USA) and pseudocoloured in green; and (3)
clones within the change were labelled with Spectrum Orange
dNTP (1.6 nmole, Vysis) and pseudocoloured in red (fig 1). In
all, seven different clones from within the CNVs were tested
(tables 1 and 2). Metaphase chromosomes from each subject
were derived from normal B lymphocytes as previously
described (www.riedlab.nci.nih.gov/protocols.asp). After hybri-
disation, slides were washed three times in 50% formamide and
2XSSC at 45uC and subsequently in 1XSSC at 45uC. Biotin
labelled flanking clones were detected by incubating hybridised
slides with a 1:200 dilution of Streptavidin Cy5 Ab. Slides were
stained with DAPI and mounted with antifade (phenylene
diamine).
Slides were imaged with an Olympus BX61 microscope with an
UPlanSApo 100X NA 1.4 objective, an Hg arc lamp for excitation,
and narrow band filters for all fluorescent emission. FISH image
acquisition was done with a COOL-1300 QS SpectraCube camera
(Applied Spectral Imaging, Vista, California, USA) using the
FISHView software (version 4.0; Applied Spectral Imaging).
Images of chromosome metaphases and interphase cells were
acquired for each patient; a minimum of 10 metaphases and 10
interphase cells were analysed for each slide.
Oligonucleotide microarray analysis
A custom 385 000 oligonucleotide NimbleGen fine tiling array
spanning positions 1 900 000–3 100 000 on chromosome 3 was
designed to map the variations in finer detail (fig 2A,B). Probes
were selected from repeat masked sequence at an average spacing
Figure 1 Fluorescence in situ hybridisation (FISH) validation of chr3p26.3 copy number variations (CNVs). (A) Validation of chr3p26.3
microduplication. FISH analysis confirmed the chr3p26.3 microduplication in subject 1 and his father (FISH images from subject 1 pictured). Panel order
from left to right: composite image, left flanking clone (yellow), right flanking clone (green), clone within the CNV (red). (B) Validation of chr3p26.3
microdeletion. FISH analysis confirmed the chr3p26.3 microdeletion in 2B, 2C and their father (FISH images from subject 2C pictured). Panel order from
left to right: composite image, left flanking clone (yellow), right flanking clone (green), clone within the CNV (red). (C) Normal chromosome 3. (D)
Chromosome 3 with duplication. Comparison of red signal intensity in (C) versus (D) demonstrates a duplication. (E) Ideogram of clone locations. Three
bacterial artificial chromosomes (BACs) were selected for each CNV: a left clone flanking the CNV pseudocoloured yellow (RP11-204C23), a right clone
flanking the CNV pseudocoloured green (RP11-95E11), and clone within the CNV pseudocoloured red (RP11-129K1).
Table 1 FISH validation of chr3p26.3 microdeletion
Region BAC
Subject
2A
Subject
2B
Subject
2C Mother Father
Outside RP11-204C23 Normal Normal Normal Normal Normal
Inside RP11-129K1 Normal Deleted Deleted Normal Deleted
Inside RP11-587N5 Normal Deleted Deleted Normal Deleted
Inside RP11-35L22 Normal Deleted Deleted Normal Deleted
Inside RP11-33J20 Normal Deleted Deleted Normal Deleted
Inside RP11-129L14 Normal Deleted Deleted Normal Deleted
Inside RP11-119L4 Normal Deleted Deleted Normal Deleted
Inside RP11-916L15 Normal Deleted Deleted Normal Deleted
Outside RP11-95E11 Normal Normal Normal Normal Normal
BAC, bacterial artificial chromosome; CNV, copy number variation; FISH, fluorescence
in situ hybridisation.
FISH was performed on subjects 2A, 2B, 2C and their parents with 2 BACs flanking
the CNV (RP11-204C23 and RP11-95E11) and a third BAC within the CNV.
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12 Hybridisationswere
performed at the NimbleGen Service Laboratory as previously
described.
12 Data were extracted from scanned images using
NimbleScan version 2.3 extraction software. Extracted data were
processed with SegMNT. Rearrangement breakpoints were
determined by automated segmentation analysis of data sets
after normalisation of signal intensities. The test versus reference
log2 ratios were averaged at window sizes corresponding to 16
and 106the median probe spacing.
Polymerase chain reaction
PCR primers (DelF-TGAGTTCACTACATGATGAGAGATAA
and DelR-TCCAGTAGTCTCGCTTAAAAATTG) were
designed from the deletion end points identified by oligonucleo-
tide microarray analysis (fig 3A). Primers (DupF-
GGCCAGCATATTTCTCCAAA and DupR-AAATCTGGCC
GAAGTTCTGA) were designed from the duplication end
points identified by oligonucleotide microarray analysis
(fig 3B). PCR was performed on sample DNAs and on a control
DNA sample known to be absent for the mutations. All PCR
reactions were performed in a 50 ml mixture containing 50 ng
DNA, 0.2 mM dNTP, 1 mM of each primer, 1.25 UHotMaster
Taq polymerase, and 1XHotMaster buffer (Fisher Scientific,
Pittsburgh, Pennsylvania, USA). Cycling was: 95uC for 5 min,
followed by 30 cycles of 95uC for 30 s, 60uC for 30 s, and 68uC
for 30 s, followed by a final extension at 68uC for 10 min. PCR
reactions were analysed with an HDA-GT12 Genetic Analyzer
(eGene Inc, Qiagen, Valencia, California, USA); products only
amplified from individuals with the specific copy number
change were analysed (fig 2C,D). PCR products were sequenced
to determine the exact end points of the mutation.
Alu analysis
Coordinates of Alu sequences within the human genome were
extracted from the RepeatMasker track of the UCSC Genome
Browser (March 2006 release).
13 The coordinates were used to
extract the DNA sequences from FASTA files downloaded from
the UCSC genome database. Alu sequences were pairwise
aligned using FASTA.
14 For each Alu, the number of Alu
elements within 5 Mb that contained at least one stretch of 75
bases at 100% identity was counted. These data were uploaded
as a custom track onto the UCSC Genome Browser (fig 4).
RESULTS
Clinical reports
Subject 1 was evaluated for this study at the age of 7 years and
9 months with ASD. He was born full term following an
uncomplicated prenatal course to non-consanguineous
Caucasian parents. Family history was not significant.
Parental concern first arose at 2 years of age due to speech
delay. His first single words were noted between 18–24 months
of age and phrase speech was absent until 3 years of age. He
underwent brain magnetic resonance imaging (MRI) and
electroencephalography (EEG) at 3 years of age which were
reportedly normal. Seizures, regression, self injurious beha-
viours, auditory and visual deficits were absent. Initial evalua-
tion for ASD was performed at age 2 (1996). At a follow-up
examination at age 6, an ADOS was administered and subject 1
met cut-off for ASD with the following scores: communication
= 3; social = 6; communication + social = 9. On physical
examination for this study, the subject’s height, weight and
head circumference were at the 95th, .95th and 50th centile,
respectively. Dysmorphic features included overfolded and low
set ears, synophrys, mild hirsutism, a broad chest and narrow
hands with a flat hypothenar eminence.
Subjects 2A, 2B and 2C are three non-twin full siblings who
were evaluated, respectively, at the ages of 19 years 3 months,
15 years 11 months, and 10 years 11 months with ASD, again
for this study. All were born full term following uncomplicated
prenatal courses to the same non-consanguineous, reportedly
non-autistic, Caucasian parents. The family history was
significant for three unaffected paternal half siblings.
Subject 2A was a normally developing male until 18 months
of age, with multiple single words and the ability to recite the
alphabet (by parental report) before losing all speech and
developing repetitive self stimulating behaviours. He underwent
a brain MRI, head computed tomography (CT) and EEG at
4 years of age which were reportedly normal. Seizures, self
injurious behaviours, auditory and visual deficits were absent.
Initial evaluation for ASD was performed at age 3 years (1987).
Subject 2A demonstrated a complete lack of speech, poor eye
contact, and tried to remain distant in physical proximity from
the clinician. He did not mimic any action or comply with any
overt requests. Parents reported (on PDD checklist and in parent
interview) an inability to socialise with peers or understand the
emotions of others, lack of reaction to events (happy or sad), a
fixation with ears and toes, lack of a sense of danger, flapped
hands (particularly when excited) and extreme sensitivity to
loud noises. At the time of evaluation for this study, the subject
had regained some use of single words and short phrases. On
physical examination (this study), his height, weight and head
circumference were at the 25th, 5th and 75th centile,
respectively. No significant dysmorphology was identified aside
from a short philtrum, narrow hands and mild ligamentous
laxity. He is the only sibling to have an early regressive course.
Subject 2B is a male who did not develop any speech until
4 years of age. He also developed seizures at 15 years of age.
Regression, self injurious behaviours, auditory and visual
deficits were absent. Initially this subject was evaluated for
ASD at the age of 2 years (1990). On examination, the subject
was restless and uncomfortable. There were no intelligible
words but he did make sounds. He did not interact appro-
priately with toys and resisted eye contact and touching by
interviewer. Parents reported immaturity for his age, separation
problems, tantrums, resistance to demands, inability to
recognise familiar objects, and lack of interactive play. On
physical examination for this study, his height and weight were
at the 25th and 50th centile, respectively. There were no
significant dysmorphic features.
Subject 2C is a female noted to have speech delay at 2 years of
age with minimal use of single words. Regression, seizures, self
Table 2 FISH validation of chr3p26.3 microduplication
Region BAC Subject 1 Mother Father
Outside RP11-204C23 Normal Normal Normal
Inside RP11-129K1 Duplicated Normal Duplicated
Inside RP11-587N5 Duplicated Normal Duplicated
Inside RP11-35L22 Duplicated Normal Duplicated
Inside RP11-33J20 Duplicated Normal Duplicated
Inside RP11-129L14 Duplicated Normal Duplicated
Inside RP11-119L4 Duplicated Normal Duplicated
Inside RP11-916L15 Duplicated Normal Duplicated
Outside RP11-95E11 Normal Normal Normal
BAC, bacterial artificial chromosome; CNV, copy number variation; FISH, fluorescence
in situ hybridisation.
FISH was performed on subject 1 and his parents with 2 BACs flanking the CNV
(RP11-204C23 and RP11-95E11) and a third BAC within the CNV.
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An ADOS was performed at age 4 (1997). The subject met the
cut-off for ASD: communication = 4; social = 6; commu-
nication + social = 10. On physical examination for this study
her height and weight were both above the 95th centile.
Significant but not syndrome specific dysmorphic features
included bilateral pre-auricular tags, mildly protruding ears,
narrow hands, ligamentous laxity, obesity and a single ,5c m6
5 cm abdominal cafe ´-au-lait spot.
All four subjects were chromosomally normal and fragile X
negative. Rett MECP2 testing was not indicated in any patient.
Molecular analysis
Whole genome array comparative genomic hybridisation
(aCGH) analysis of 92 subjects with ASD identified a CNV at
3p26.3 in three subjects. A deletion spanning ,2 205 400–
2 859 400 on chromosome 3 was detected in two siblings
(subjects 2B and 2C) and a duplication spanning ,2 003 900–
2 795 000 on chromosome 3 was detected in a third unrelated
individual (subject 1) (data not shown). Subsequent array
analysis of parental DNA revealed that both variations were
paternally inherited. FISH of metaphase spreads from both
families confirmed the array findings (fig 1, tables 1 and 2). A
custom oligonucleotide array spanning positions 1 900 000–
3 100 000 on chromosome 3 was designed to map the changes
in finer detail. Since the changes were inherited, the mutation
end points where assumed identical within each family and
only subject 2C and subject 1 were hybridised. The deletion was
mapped to roughly chr3: 2 205 425–2 859 375 and the duplica-
tion to roughly chr3: 2 003 928–2 795 025 (fig 2A,B). This
information was used to design primers unique to the CNVs.
Two primers, normally 670 784 bp apart, amplified a 454 bp
product specific for the chromosome 3 deletion (figs 2C and 3A).
Sequence analysis revealed the deletion to have occurred
Figure 2 Fine Mapping of copy number variation (CNV) end points. (A) A NimbleGen fine tiling array further defines the deletion end points. A
NimbleGen fine tiling array spanning positions 1 900 000–3 100 000 on chromosome 3 was used to map the deletion in greater detail. The log2 ratio
(test/reference) deviates from 0 at positions ,2 205 400–2 859 400, indicating the deletion breakpoints on chromosome 3. (B) A NimbleGen fine tiling
array further defines the duplication end points. The same fine tiling array utilised in (A) was used to map the duplication in greater detail. The log2 ratio
(test/reference) deviates from 0 at positions ,2 003 900–2 795 000, indicating the duplication breakpoints on chromosome 3. (C) Polymerase chain
reaction (PCR) across the deletion. PCR with primers spanning the deletion yielded a 454 bp product in subject 2C (A02), subject 2B (A03) and their
father (A06). No product was present in subject 2A (A04), their mother (A05), a normal control (A07) or water (A08). See also fig 3A. (D) PCR across
the duplication. PCR with primers between the duplicated regions on chr3 yielded a 520 bp product in subject 1 (A02) and his father (A04). No product
was amplified from his mother (A03), a normal control (A05) or water(A06). See also fig 3B.
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chr3: 2 857 104–2 857 410. Primers normally 790 018 bp apart
were designed to map the duplication end points. Amplification
yielded a 520 bp product specific to the CNV (fig 2D and 3B).
Sequencing of the product revealed that the duplication resulted
from of unequal recombination between an Alu Y at chr3:
2 004 085–2 004 406 and chr3: 2 794 618–2 794 952. The tan-
dem duplication directly interrupts CNTN4 (fig 3B).
Alu sequences from the region chr3: 1 850 000 to 3 100 000,
which spans CNTN4, were analysed for homology to other
nearby Alu elements. For each Alu in this region, a comparison
was made with all other Alu elements mapping within 5 Mb
(on either side). Those that contained at least 75 contiguous
bases of 100% identity with another Alu were plotted (fig 4). Of
the 356 Alus annotated in the UCSC genome database within
this region, 25 were found to match one or more Alus within
5 Mb. All of these Alus are of the AluY (or one of its subtypes)
class of Alus. This represents 43% of the AluY sequences in the
region.
DISCUSSION
The CNVs described in our subjects directly interrupt contactin
4( CNTN4), an axon associated cell adhesion molecule
(AxCAMs) highly expressed in the brain, particularly in the
cerebellum, thalamus, amygdala, and cerebral cortex.
15 Complex
interactions between cell adhesion molecules (CAMs) are of
critical importance during neurogenesis and the precise func-
tioning of neural networks. AxCAMs are believed to play crucial
roles in axonal elongation along specific pathways, fasciculation
of specific axonal populations, and the formation, maintenance,
and plasticity of some synaptic connections.
16 The expression
profile of CNTN4 in human tissues indicates that the protein
may have an important role in both the early growth of
developing axons and in the maintenance of the adult nervous
Figure 3 Diagram of polymerase chain
reaction (PCR) primer design. (A)
Amplification of chr3p26.3 deletion
specific product. Primers DelF and DelR
were designed to amplify a 454 bp
product specific to the observed deletion.
In normal genomic DNA, there primers
are 670 784 bp apart and do not generate
a product. (B) Amplification of chr3p26.3
duplication specific product. Primer DupF
and Duper were designed to amplify
520 bp product specific to the observed
tandem duplication. In normal genomic
DNA, these primers are 790 018 bp apart
and face opposite directions.
Figure 4 Histogram of Alu sequences near CNTN4. Alu sequences containing 100% identity of 75 bases or more to other Alu sequences within 5 Mb
were plotted on the UCSC Genome Browser. The position of each Alu element found to match at least one other Alu, using this criterion, is denoted by a
vertical bar. The height of each bar represents the number of ‘‘hits’’.
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16 In 2004, Fernandez et al reported a de novo balanced
translocation, disrupting CNTN4, in a patient with the cardinal
features of 3p deletion syndrome, including developmental
delay and typical dysmorphic features.
15 Other groups have also
suggested that loss of a single functional copy of CNTN4
contributes to the developmental delay characteristic of 3p
deletion syndrome.
17 18
The syndrome is clinically recognised by a combination of
features including growth and mental retardation, micro-
cephaly, hypertonia, digital anomalies and dysmorphic facial
features including a triangular shaped face, ptosis, hypertelor-
ism, broad nasal root, long philtrum, down turned mouth,
micrognathia and dysplastic ears.
15 19 20 In this report, none of
the subjects with CNVs interrupting CNTN4 demonstrated the
classical 3p deletion syndrome phenotype. Quite notably,
growth retardation, microcephaly, digital anomalies, hypertonia
and the characteristic facial gestalt were absent and only minor,
non-specific dysmorphic features were identified. This is in
contrast to previous reports of CNTN4 deletion or interruption
by translocation where aspects of the 3p deletion syndrome
phenotype were described.
15 As previously reported deletions
involving CNTN4 encompassed neighbouring genes, and as
translocations may similarly result in position effects on
neighbouring genes, it is intriguing to observe that the
intragenic CNTN4 CNVs identified in this report have been
ascertained through the presence of a relatively isolated
neurocognitive phenotype.
15 Interestingly, mutations of con-
tactin associated protein-like 2 (CNTNAP2) have also been
linked to ASD and/or features of the syndrome, including
seizures, language regression, and mental retardation.
21–24
Therefore, given CNTN4’s vital role in both the development
and maintenance of the nervous system, its implication in 3p
deletion syndrome, and the correlation of associated proteins
with autism, we believe mutations affecting the protein’s
function may contribute to ASD pathogenesis.
In our subjects, the CNVs interrupting CNTN4 were all
inherited from fathers without a history of ASD; one
consideration is that these CNVs are polymorphic and not
pathologic. There have been a few rare reports of CNVs
affecting CNTN4 in normal individuals (Database of Genomic
Variants, http://projects.tcag.ca/variation/).
25 However, most
of the described variations were detected with the Affymetrix
500K EA SNP Mapping Arrays, and, for the most part, have not
been validated. It may be difficult to equate data from different
platforms when it comes to copy number. In addition, the
normal variation reported in the Database of Genomic Variants
needs to be interpreted with care. The database lists several
CNVs that would be expected to cause well known syndromes,
including velo-cardio-facial syndrome, 22q13 deletion syn-
drome, and Sotos syndrome. It is also noteworthy that an
ongoing study, in our own group, utilising the same BAC array
platform and analysis methods applied with this cohort, failed
to identify CNVs involving CNTN4 in 560 National Institutes
of Mental Health (NIMH) unrelated normal controls. Studies of
other disorders (unrelated to ASD), also in our own group, have
also failed to detect CNVs in this gene in 252 individuals (data
not shown). If mutations of CNTN4 are incompletely pene-
trant, disruption of the gene, although rare, may not result in
ASD in all detected cases. The significance of an incompletely
penetrant mutation is perhaps best examined between families
instead of individuals. This study recruited 92 subjects from 81
different families. A CNV disrupting CNTN4 is present in two
families (,2.5%). However, as mentioned above, BAC micro-
array analysis did not detect a variation affecting CNTN4 in
normal controls (data not shown). Assuming each normal
individual is representative of a different family, statistical
analysis of these findings with a Fisher Exact Test (http://
www.physics.csbsju.edu/stats/fisher.form.html) indicates loss
of one functional copy of CNTN4 is a significant contributing
factor to the development of ASD (p=0.016). Although these
results need further confirmation in larger cohorts, they
strongly suggest that mutations affecting CNTN4 function
can cause ASD, despite their detection in a small number of
reportedly normal individuals. Notably, incomplete penetrance
has been described in other ASD associated mutations, including
a chromosome 16p11.2 CNV that reportedly accounts for
approximately 1% of all cases of the syndrome.
26 The CNV was
a de novo event in most subjects, but additionally was inherited
in some individuals from an unaffected parent. It was also
found to occur rarely in normal controls as well.
It is noteworthy that studies of large scale CNV in the human
genome, to date, have not examined their cohort’s family
history. Given the prevalence of ASD (1 in 150 American
children), it is possible that ‘‘normal’’ individuals with CNVs
affecting CNTN4 come from families with the disorder. Had the
two fathers described in our study been part of a normal cohort,
it is unlikely that the presence of ASD in their children would
have been noted. Consider the case of thrombocytopenia-absent
radius (TAR) syndrome. A recent study of the disease identified
a 200 kb deletion on chromosome 1 in all 30 TAR patients
examined.
27 In a majority of cases, the deletion was inherited
from an unaffected parent but the variation was completely
absent from a group of 700 normal individuals. This suggests
that the deletion contributes to TAR syndrome but the
phenotype only develops in the presence of an as-yet-unknown
modifier. Disruption of CNTN4 may affect the development of
ASD in a similar manner. Imprinting, environmental inter-
actions, or other factors may determine how mutations in
CNTN4 cause ASD.
It is worth mentioning that subject 2A has ASD but does not
carry the chromosome 3 CNV. However, he is the only child in
his family to have an early regressive course, suggesting perhaps
that his disease is somehow different from his siblings. Also of
interest is the fact that this phenomenon has been described in
ASD before. The Autism Research Consortium observed a
22q11.2 duplication in two multiplex families. In one, it was
inherited from a parent, while in the other it was de novo.
28 In
both families, only one child diagnosed with ASD carried the
duplication. Alarcon et al describe a large intronic deletion in a
multiplex family inherited in one autistic sibling but not the
other.
22 Given the frequency of ASD in the general population, it
is possible that, on occasion, individuals from the same sibship
may have the syndrome for different reasons.
Key points
c A genetic study of autism spectrum disorder (ASD) identified
paternally inherited copy number variations (CNVs) of chr3p26
in three individuals with the disorder.
c The CNVs affected one gene directly, contactin 4 (CNTN4).
CNTN4 participates in neurogenesis and functioning of neural
networks. Disruption of this gene is known to cause
developmental delay and mental retardation.
c Molecular characterisation of the CNVs revealed that they
resulted from Alu Y mediated unequal recombination.
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mediated unequal recombination. Rearrangements involving
Alus, in general, are most likely to occur between repeat
elements on the same chromosome located within 5 Mb of each
other with high sequence identity.
29 The Alu Y mediated
rearrangements reported here fit these criteria, as do 43% of the
Alu Y elements around CNTN4. The high degree of Alu Y
homology in this region perhaps predisposes it to Alu Y
mediated unequal recombination. However, although Alu
density may contribute to these recombination events, other
factors likely influence the rearrangements. Analysis of other
Alu-rich genes has found there is not a direct correlation
between Alu density and recombination rate.
30 Some other
factors likely contribute to the recombination events observed
in our subjects and the high Alu Y density in the region likely
aids in the process.
30
Our work implicates CNTN4 as a candidate gene in ASD.
Ongoing efforts are underway to sequence the gene in large
numbers of subjects with ASD and normal controls to identify
subtle mutations that might be involved in pathogenesis.
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